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Wound management represents a major clinical challenge on what concerns healing enhancement and pain
control. The selection of an appropriate dressing plays an important role in both recovery and esthetic ap-
pearance of the regenerated tissue. Despite the wide range of available dressings, the progress in the wound care
market relies on the increasing interest in using natural-based biomedical products. Herein, a rat wound-
dressing model of partial-thickness skin wounds was used to study newly developed chitosan/soy (cht/soy)-
based membranes as wound-dressing materials. Healing and repair of nondressed, cht/soy membrane-dressed,
and Epigard-dressed wounds were followed macroscopically and histologically for 1 and 2 weeks. cht/soy
membranes performed better than the controls, promoting a faster wound repair. Re-epithelialization, ob-
served 1 week after wounding, was followed by cornification of the outermost epidermal layer at the second
week of dressing, indicating repair of the wounded tissue. The use of this rodent model, although in impaired
healing conditions, may enclose some drawbacks regarding the inevitable wound contraction. Moreover,
being the main purpose the evaluation of cht/soy-based membranes’ performance in the absence of growth
factors, the choice of a clinically relevant positive control was limited to a polymeric mesh, without any growth
factor influencing skin healing/repair, Epigard. These new cht/soy membranes possess the desired features
regarding healing/repair stimulation, ease of handling, and final esthetic appearance—thus, valuable prop-
erties for wound dressings.
Introduction
Tissue repair and scar formation are main concerns ofwound care. The appropriate dressing selection plays an
important role both in the complete regeneration of the in-
jured tissue and in the esthetic appearance.1 A wide range of
dressings and bandages, adaptable to various types of
wounds, are nowadays available in the wound care market,
and are currently used in the clinics. The traditional wound
dressing that simply covered and protected the wound2,3 has
been replaced by alternative dressings that allow control of
wound moisture4–7 and, more recently, by dressings with an
(bio-) active role in the healing environment.8,9 However,
most of the existing products need to be changed every few
days after their application; in some cases, there is the need
to replace the material to maintain/accelerate the ongoing
healing process.10 Therefore, further developments that
facilitate the healing process or address issues such as the
control of the chemical environment and bacterial infection
are required and desired.
Indiscriminately, synthetic,11–14 natural,8,15,16 or biological
materials10,17,18 have been presented along the years, as the
key elements for controlling/modulating the healing mech-
anisms and the outcomes of wound repair upon dressing.10
Among the recently proposed natural-origin materials for
wound dressing, collagen2,9,19 chitosan,20–24 and silk25,26 oc-
cupy a central position due to their nature, which might
present improved performance.
The positive impact of chitosan, a deacetylated derivative
from chitin, concerning the healing mechanisms that in-
clude the inflammatory process, is well documented. The
demonstration of the chitosan anti-inflammatory activity
and potential in promoting wound healing was reported by
Mori et al.27 Although chitosan activates macrophages, it
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also induces gradual macrophage apoptosis in vitro (about
50% programmed cell death in 6 h),27 thus preventing the
possible occurrence of septic shock and death.28 Macro-
phage activation induced by chitosan resulted in increased
metabolic activity, secretion of cytokines, growth factors
and inflammatory mediators, and enhanced phagocytic
activity.27 The production of macrophage inflammatory
protein-2 (MIP-2) by chitosan-activated macrophages
stimulates epithelial cell proliferation29 and thus skin heal-
ing. Additionally, a reduction on the influx of activated
tissue macrophages, which in turn decreases angiogenesis,
fibroplasia, and connective tissue deposition, was also at-
tributed to chitosan.30 These features may substantiate the
hemostatic properties preventing bleeding,30 as well as the
antibacterial activity when applied in skin wounds22,24,31
that chitosan also displays. In a clinical trial, Azad et al.32
have shown a positive effect of chitosan both on the re-
epithelialization and regeneration of the granular layer of
the skin where chitosan-dressed wounds healed faster
compared to controls. These data are in agreement with
other studies demonstrating that chitosan induce the mi-
gration of polymorphonuclear neutrophils (PMNs) at the
early stage of wound healing, when treating open skin
wounds in dogs, enhancing the formation of granulation
tissue and production of collagen by fibroblasts.33 In addi-
tion, we have previously demonstrated that PMNs are not
activated by chitosan and, therefore, an acute inflammatory
response will not persist at the wound site in the presence of
chitosan.34
Soybean-rich foods have been recognized to decrease the
risks of chronic diseases and protective effects against per-
sistent inflammation.35 These features are mainly attributed
to isoflavones.35 Among the isoflavones, genistein, a phy-
toestrogen, showed to have favorable effects on cutaneous
wound healing36,37 through an estrogen receptor-indepen-
dent mechanism.36 Additionally, it was demonstrated that
genistein is able to signal, via mitogen-activated protein ki-
nase (MAPK) activation in macrophages, reducing wound
pro-inflammatory cytokines.36
Chitosan/soy (cht/soy) membranes were previously
proposed for biomedical applications based on the observa-
tions of their in vitro capacity to enhance the proliferation of
fibroblasts38 and their impaired ability to activate PMNs.34
Additionally, a normal host reaction was observed after
subcutaneous implantation in rats.39 Other important fea-
tures of these cht/soy membranes, critical for wound
dressings, are their simple manipulation and their transpar-
ency. In this context and on the worldwide-recognized po-
tential of chitosan and soy-based components for skin
wounds regeneration, the aim of this study was to evaluate
the suitability of newly developed cht/soy-based mem-
branes as dressings for partial thickness skin wounds.
Among the many different animal models to study wound
healing and skin regeneration, excision of rat skin portions is
a model widely used.8,17,22,40–45 Therefore, a wound-dressing
rat model of partial-thickness skin wound, under impaired
healing conditions, was used to assess the suitability of the
cht/soy membranes to promote wound healing. Compara-
tively, Epigard, a clinically accepted wound dresser, was
used as control. Epigard is also only a dressing without any
further active substances.12,46 Thus, it is a clinically widely
used dressing similar to the one studied here.
Materials and Methods
Materials
Cht with a deacetylation degree of about 85% was pur-
chased from Sigma, and the soy protein isolate (SI) was pro-
vided by Loders Crocklaan. All other reagents were analytical
grade and used as received. Cht/soy protein-blended mem-
branes (average thickness of 84mm and 17mm of diameter)
were prepared by solvent casting according to a procedure
described elsewhere.38 Briefly, chitosan was dissolved in an
aqueous acetic acid 2% (v/v) solution at a concentration of
4wt%. A soy suspension (1wt%) was prepared by slowly
dispersing the soy protein powder, under constant stirring, in
distilled water with glycerol. After adjusting the pH to 8.0– 0.3
with 1M sodium hydroxide, the dispersion was heated in a
water bath at 50C for 30min. The cht and the SI solutionswere
mixed at a weight ratio of 75/25% cht/soy (CS75). After
homogenization, the CS75 solution was casted into Petri
dishes and dried at room temperature for 6 days. The neu-
tralization of the membranes was obtained by immersion in
0.1M sodium hydroxide for about 10min. Membranes were
washed with distilled water to remove all traces of alkali and
then dried at room temperature. The materials were sterilized
under standard conditions with ethylene oxide.47
Animals
Twenty male Sprague-Dawley rats weighting between 230
and 280 g were used for the study. Three groups were in-
vestigated: membranes (wound directly covered with the
cht/soy-based membranes); positive control (wound directly
covered with Epigard—Biovision GmbH); and negative
control (no direct coverage of the wound). Epigard is com-
posed of a nontextile outer layer of polytetrafluorethylene
and an inner layer of soft elastic polyurethane that forms an
open matrix to which adsorbs the exudate from the wound
bed. This dressing was chosen as positive control because it
is extensively used in the clinical practice as a short-term
wound dressing without growth factors.12,46
Each animal was anesthetized with an intramuscular in-
jection of 90mg/kg of ketamine combined with 5mg/kg
xylazine after induction with 3%–3.5% isofluorane and 7L/
min of air for 2–3min. After shaving the skin, the back of the
animals was disinfected and two paravertebral wounds
(17mm in diameter) were created by excision, leaving the
skin smooth muscle layer ( panniculus carnosus) intact. The
test conditions were randomly distributed among the ani-
mals (Table 1). After dressing (except the negative control),
the wounds were protected with Bactigras (Smith & Ne-
phew) and then covered with Opsite Flexigrid (Smith &
Nephew). Bactigras is a paraffin gauze dressing containing
0.5% of chlorhexidine acetate; being soothing and nonadhe-
sive, it allows the wound to drain freely into an absorbent
secondary dressing.32 Opsite Flexigrid, a vapor-permeable
adhesive film dressing that is the standard in moist wound
healing48 was used as a secondary dressing. The whole ab-
domen of each animal was protected with stretching ban-
dages to prevent the removal of the whole set of dressings by
scratching and biting (Fig. 1). At days 0 (surgery day) and 7,
methylprednisolone acetate (Depo-Medrol; Pfizer) was
subcutaneously injected (20mg/kg BW) to impair wound
healing49 and inhibit hair growth.
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The animals were kept separately and received daily an-
algesia with metamizole sodium (200 mg/g BW) and sedation
with diazepam (2.5mg/125mL water) in drinking water.
The bandages were changed every 3–4 days. Macroscopic
analysis of the wounds was carried out at days 3, 7, and 14
and the images taken used for the planimetric evaluation of
the healing process. The evaluation was performed with the
LUCIA G version 4.8 (Laboratory Imaging Ltd.) software
by two independent researchers blinded to the experimental
condition.
After 1 and 2 weeks, the animals were anesthetized with
isoflurane and then euthanized by and intracardial overdose
of ketamin/xylazine. The wound area and the surrounding
healthy skin were explanted. Central wound cross sections
were performed and samples were fixed for histological
analysis, in 3.7% formalin, and then paraffin embedded,
sectioned, and stained according to a routine hematoxylin
and eosin protocol.
The histological samples were analyzed using an Ax-
ioplan Imager Z1 microscope (Zeiss) and included the
measurement of the length of the wound, allowing the es-
tablishment of a correlation with the planimetric assessment
of the wound areas. The planimetric assessment comprises
the wound area. This area is diminished during healing by
contraction and epithelialization. These entities cannot be
separated, but are present in all the groups. The full
wounded area and the healthy margins images were then
obtained after the composition of multiple standardized
histological pictures.
Statistical analysis
Data from the planimetry and from the wound length
measurements50 were analyzed by a single-factor ANOVA
test and the significance value was set at p< 0.05.
Results
Macroscopic analysis
The macroscopic characterization of the wounds during
the observation period was based on the planimetric analysis
of the wounded area. A qualitative evaluation of the healing
area and interface regions between healthy and newly
formed tissue was also performed.
At day 3 after wounding and dressing, clear macroscopic
differences between the groups were observed (Fig. 2A). The
cht/soy membrane-dressed wounds showed a significant
infiltration of granulation tissue that led to membrane lifting
and allowed wound observation. Conversely, the non-
dressed wounds (negative control) showed bleeding, which
is a sign of impaired healing. Epigard (positive control) had
completely adhered to the wound bed, making it impossible
to be removed without further wounding (Fig. 2A). At this
stage, the planimetric analysis revealed that the areas of the
undressed (negative control) and of the cht/soy membrane-
dressed wounds were not significantly different ( p > 0.05)
(Fig. 2B). The wounded area of the negative control was
significantly smaller ( p< 0.05) than that of the positive
control (Fig. 2B).
FIG. 1. Macroscopic
appearance of the wounds
created by skin excision and
before dressing (A). Aspect of
the animal with the whole set
of dressings and bandages
(B). Color images available
online at www.liebertpub
.com/tea
Table 1. Summary of the Random Distribution
of the Study Groups for Each Animal, and the
Total Number of Samples Considered for Each
Group, at 1 and 2 Weeks of Implantation
Animal
number
Left
lesion
Right
lesion
Healing time
period
Total
A
Total
B
Total
C
1 A C 1 week 6 6 6
2 B A
3 C B
4 A B
5 B C
6 C A
7 A B
8 B C
9 C A
10 A C 2 weeks 6 6 6
11 B A
12 C B
13 A B
14 B C
15 C A
17 A B
17 B C
18 C A
A, wounds treated with chitosan/soy-based membranes; B,
wounds treated with Epigard (positive control); C, nontreated
wounds (negative control).
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Despite some scratching of the secondary bandages, after
7 days of dressing no signs of infection were detected in any
of the test groups (Fig. 2A). After this time period, the new
epithelial tissue started to replace the granulation tissue in
the cht/soy membrane-dressed wounds, and the membranes
were easily lifted from the wound bed without bleeding. An
improved healing was observed for the cht/soy membrane-
covered wounds versus the negative control, where some
granulation tissue was still present (Fig. 2A). In contrast
Epigard completely adhered to the wound bed, avoiding
new epidermis formation, and an attempt to remove it led to
bleeding (Fig. 2A). Compared to both controls, the wounds
dressed with the cht/soy membranes showed thinner mar-
gins with an almost complete healing and new tissue for-
mation replacing the excised epidermis (Fig. 2A). The wound
of the negative control revealed a significant degree of con-
traction. Despite the smaller wound area of the cht/soy
membrane group, at day 7 the planimetric evaluation did not
reveal significant differences in comparison to both controls
( p> 0.05) (Fig. 2B).
The macroscopic analysis showed that the wound area
significantly decreased from the operation day to the final
excision time point (14 days) in all the tested conditions,
which is an indication of neoepithelialization and replace-
ment of the wounded tissue (Figs. 2A, B) by newly formed
tissue. A significant and consecutive reduction of the wound
area was gradually observed in both negative and positive
controls, although with a significantly delayed wound clo-
sure (Figs. 2A, B). While comparing the contour and di-
mensions of the wounds at day 14 (Figs. 2A, B), it was
evident that the re-epithelialization and healing was also
more efficient in the wounds dressed with the cht/soy-based
membranes.
Histological analysis
After the first and second week of dressing, the wounds
and surrounding healthy skin were excised, together with
the attached dressing in the case of the positive controls, and
histological analysis was performed. As during the process
of sectioning and staining, the adherent Epigard did not
detach from the wound bed, the analysis of the explants
included its integration with the growing tissue.
One week after dressing, the cht/soy-based membranes
(Fig. 3A, C, E) seemed to enhance the formation of granu-
lation tissue, in comparison to the negative control (un-
dressed wounds) (Fig. 4A, C, E). Furthermore, the margins of
the cht/soy membrane-dressed wounds presented a conti-
nuity of the repairing tissue (Fig. 3E) that was not observed
in the wound margins of the negative (Fig. 4E) and positive
(Fig. 5E) controls. At this stage of healing, it was already
possible to identify some stratification of the tissue in the
membrane-dressed wounds (Fig. 3C). These features were
not detectable either in the negative (Fig. 4C) or in the pos-
itive controls (Fig. 5C). A disorganized mesh of cells, in-
cluding a large amount of inflammatory cells, some
fibroblasts, and collagen fibers, were observed in both
groups. Furthermore, necrosis was detected in the
FIG. 2. Representative images of the
macroscopic aspect of the excisional
wounds at the operation day (OpD)
and subsequent healing at days 3, 7,
and 14 after dressing with the
chitosan/soy-based membranes, and
in comparison with the negative and
positive controls (A). Follow-up of the
wound area determined by planimetric
analysis (B). *Differences statistically
significant; A, , and p< 0.05 versus
OpD; Cp< 0.05 versus negative control
at day 3 of dressing; Op < 0.05 versus
positive control at day 7 of dressing;
fp< 0.05 versus membrane dressing at
day 7. Color images available online at
www.liebertpub.com/tea
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nondressed wounds (Fig. 4C) but not in the Epigard-
dressed wounds (Fig. 5C). In fact, the material adhered to the
wound bed and formed an intimate network composed by
the polymer matrix and the inflammatory cells. This network
started to vascularize, indicating a good integration of the
material into the wound bed (Fig. 5C). During the first week
of healing the presence of foreign body giant cells was not
detected in all test groups.
At the second week of dressing, the healing of the wounds
covered by the cht/soy membranes (Fig. 3B, D, F) was
FIG. 3. Representative
composition of the
histological micrographs of
the wounded skin (A, B) and
detailed micrographs of the
wound beds (C, D) and
margins (E, F), respectively, 1
and 2 weeks after dressing
with the chitosan/soy (cht/
soy) membrane. Boxes in
Figs. A and B represent the
higher magnifications of Figs.
C–F. Color images available
online at www.liebertpub
.com/tea
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enhanced in comparison to the negative (Fig. 4B, D, F) and
positive (Fig. 5B, D, F) controls. The wounds decreased in
size (Fig. 3B), the margins were thinner (Fig. 3F) and the
previously observed granulation tissue was replaced by a
more stratified regenerated epidermis (Fig. 3D). Cornifica-
tion of the outermost epidermal layer, although still near the
margin of the wound, was observed (Fig. 3B, D), demon-
strating clear signs of re-epithelialization. The negative con-
trols showed a severe epidermis macerating effect that was
translated in extensive necrosis of the tissue (Fig. 4B, D, F).
Regarding Epigard-dressed wounds, the matrix network
detected at the first week of healing was still present but with
FIG. 4. Representative
composition of the
histological micrographs of
the wounded skin (A, B) and
detailed micrographs of the
wound beds (C, D) and
margins (E, F), respectively, 1
and 2 weeks after dressing
with the Epigard (positive
control). Boxes in Figs. A and
B represent the higher
magnifications of Figs. C–F.
Color images available online
at www.liebertpub.com/tea
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a higher infiltration of inflammatory cells (Fig. 5D). Under-
neath the network, a significant layer of muscle and collagen
fibers was observed (Fig. 5D).
The microscopic measurement of the length of the
wounds in the histological samples did not show significant
statistical differences ( p > 0.05) among the groups after 1
and 2 weeks (Fig. 6). At the first week of healing the
wounds dressed with the cht/soy membranes showed a
significant decrease in length, in comparison to both con-
trols ( p < 0.05) (Fig. 6). Conversely, the controls did not
significantly differ in the length of the wounds ( p > 0.05)
(Fig. 6). Two weeks after healing, the positive and negative
controls showed significantly different wound lengths
( p < 0.05) (Fig. 6). In contrast, the cht/soy membranes-
dressed wounds showed lengths comparable to the nega-
tive control (Fig. 6).
FIG. 5. Representative
composition of the
histological micrographs of
the wounded skin (A, B) and
detailed micrographs of the
wound beds (C, D) and
margins (E, F), respectively, 1
and 2 weeks left undressed
(negative control). Boxes in
Figs. A and B represent the
higher magnifications of Figs.
C–F. Color images available
online at www.liebertpub
.com/tea
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Discussion
Excisional wound animal models are the most frequently
used models to investigate the performance of skin wound
dressings.51 These wounds are useful to assess re-epithelial-
ization after implantation of different devices, such as wound
dressings, topical formulations, and growth factors,51 when a
considerable volume of skin is removed. However, one
drawback of using rats as a model is the characteristic con-
traction during wound healing. Nevertheless, this occurred in
all groups investigated and is thus part of the wound healing
in these types of models. Many research groups have re-
ported the successful use of different types of chitosan-based
materials for wound-dressing applications.32,48,52–54 Taking
into consideration some of those reports and previous
knowledge on the behavior of cht/soy-based membranes,34 a
wound-dressing rat model of partial-thickness skin wound
was used to assess the suitability of these membranes as
wound dressings.
This study demonstrates that the cht/soy membranes, in a
rodent model under impaired healing conditions induced by
corticosteroid treatment,49 are suitable wound dressings, al-
lowing the progress of a normal healing path and a faster
replacement of the excised epidermis in comparison to an
undressed wound (negative control). The presence of gran-
ulation tissue at earlier stages of healing was indicative of an
accelerated tissue reaction55 toward the repair of the injured
site. In contrast, an early inflammatory reaction and bleeding
were observed in the negative control. In fact, for both neg-
ative and positive controls, a disorganized mesh of cells,
with a large amount of inflammatory cells, some fibroblasts,
and collagen fibers were observed after the first week of
healing, which is in contrast to what is observed in the cht/
soy membrane-dressed wounds. Therefore, the normal
healing cascade was not occurring in both control conditions.
In partially thickness wounds the formed granulation tis-
sue leads to wound contraction and re-epithelialization,
which closes the wounded area, allowing the regeneration of
the epidermis with its different layers and annexes.43,51
Furthermore, as the subcutaneous tissue with the portion of
the panniculus carnosus muscle in the backs of the animals is
left intact,56 the re-epithelialization of the wound is expected
to start not only from the margins of the wound containing
healthy and intact skin, but also from the wound bed.43,56
After 1 week the wounds dressed with the cht/soy mem-
brane already presented some stratification. The smaller
wound area and the thinner margins, with an almost com-
plete repair of all the layers of the excised epidermis after
14 days of dressing, confirmed the normal progress of re-
epithelialization and a better healing after dressing with the
cht/soy membrane. In contrast and despite the decreased
area, the undressed wounds showed severe necrosis and
failed in re-epithelialization. Additionally, the undressed
wound margins showed a significant depression lacking a
smooth transition from the healthy skin to the injured area.
As stated before, in all groups some contraction could be
observed but was similar in all groups. Therefore, observed
wound healing was mainly due to epithelialization.
According to a previous report,34 PMNs did not secrete
reactive oxygen species (ROS) after direct contact with cht/
soy membranes. Furthermore, the membranes exerted an
anti-inflammatory effect by inhibiting ROS production by
PMNs when stimulated with phorbol 12-myristate 13-acetate
(PMA) or formyl-methionyl-leucyl-phenylalanine (fMLP).34
It is therefore likely that the inflammatory cells present at the
wound bed of undressed wounds were secreting ROS, re-
sponsible for destroying the surrounding cells and tissues
and thus explaining the observed necrosis at the wound bed.
In addition, the observed necrosis at the wound bed of the
negative controls may be explained by the lack of stimulation
of the wound bed tissue to heal. In fact it is well known that,
as the growth from the wound margins is slower, the ab-
sence of nutrients in the wound bed leads to cell death.43 In
contrast, cht/soy membranes exerted their anti-inflamma-
tory potential by inhibiting the activation of the inflamma-
tory cells and avoiding a toxic environment in the wound
bed, which lead to normal wound healing process.
In this study, an unexpected reaction was observed for the
Epigard, independently of the time periods tested. Being a
clinically used wound dressing, the observed impaired repair
was not predicted. Of note, this dressing is not clinically used
for wounds up to the muscle layer. However, it was important
to use this dressing as it is a dressing without any biologically
active substances. Therefore, it was in our opinion the best
suitable means for comparison. The different healing rates
between rats and humans and the faster metabolism of rats,
although in impaired wound conditions, may have led to an
exacerbated reaction and to the formation of a vascularized
network of cell-embedded matrix might justify the results with
Epigard. Conversely to the cht/soy membranes that were
easily detached from the wounds, without additional trauma
and without removing the granular tissue, the Epigard in-
tegrated within the wound tissue, thus delaying the resolution
of the inflammatory process. The continued presence of the
Epigard within the wound showed that the host was still
combating the foreign body and thus was unable to proceed
with the re-epithelialization and the closure of the wound.
The overall results showed that the cht/soy-based mem-
branes induced the formation of new tissue with good histo-
logical features in a short period of time although, in
comparison to the standard controls, the wound area seems
similar at the end of the experiment. The fact that cht/soy
membranes were completely loose on the wound seemed to
FIG. 6. Representation of the length of the wound 1 and 2
weeks after dressing with the cht/soy membrane (Mem-
brane), the Epigard (Positive), and undressed (Negative).
Measurements were obtained from the histological micro-
graphs of the wounded region of the skin. *Statistically sig-
nificant differences.
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facilitate the spatial and increased progression of the newly
formed epithelium. It is also critical to emphasize that, besides
wound closure, wound dressing must promote the formation
of quality tissue, ideally without contraction. The cht/soy-
based membranes appear not only to be able to regulate the
wound moisture, which at extreme levels would impair epi-
dermis repair, but also to provide the adequate coverage that
does not physically constrain the formation of new tissue.
Despite the relevance of the observations included in this
study, the use of a rodent model in wound-dressing evalu-
ation, although in impaired healing conditions, may enclose
some drawbacks regarding the inevitable wound contrac-
tion. Furthermore, since the main purpose was the evalua-
tion of cht/soy-based membranes’ performance without
growth factors, the choice of a clinically relevant positive
control was limited to a polymeric mesh, without any
growth factor (Epigard), which had a detrimental influence
in wound healing and cutaneous repair.
Nevertheless, the present work strongly suggests that the
newly developed cht/soy-based membranes produced by
solvent casting methodology that had proven to promote
low in vitro activation of human PMNs isolated from circu-
lating blood decrease the healing time period of partial-
thickness skin wounds in impaired healing rats. Moreover,
these cht/soy-based membranes showed an enhanced per-
formance as compared to the negative and positive controls,
inducing fast re-epithelialization and wound closure.
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